Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
Abstract Background and aims COVID-19 is already a pandemic. Emerging data suggest an increased association and a heightened mortality in patients of COVID-19 with comorbidities. We aimed to evaluate the outcome in hypertensive patients with COVID-19 and its relation to the use of renin-angiotensin...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12469
- Acceso en línea:
- https://www.sciencedirect.com/science/article/abs/pii/S1871402120300564?via%3Dihub
http://hdl.handle.net/20.500.12010/12469
https://doi.org/10.1016/j.dsx.2020.03.016
- Palabra clave:
- Hipertensión
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Comorbidities
Hypertension
Angiotensin-converting enzyme inhibitors
Angiotensin-receptor blockers
- Rights
- License
- Acceso restringido